On September 15, 2023, FDA published an update to the guidance document - “Breakthrough Devices Program, Guidance for Industry and Food and Drug…
Thomas W. Greeson is a journalist who specializes in writing about healthcare and medical topics. He contributes to publications such as Mondaq and Lexology, focusing on issues related to FDA regulations, breakthrough devices, radiology, Medicare, and healthcare policy. His articles provide insights into the latest developments in the healthcare industry and their impact on medical professionals and patients.